FA
HELP

Fountainhead AM’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Fountainhead AM’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-267
Closed -$4.2K – 145
2024
Q1 		$4.2K Hold
267
– – ﹤0.01% 135
2023
Q4 		$4.16K Buy
+267
New +$4.97K ﹤0.01% 117

Other funds holding HELP

DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
ACM
Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Fountainhead AM's HELP Position: Q2 2024 in Review

Fountainhead AM sold out of Helus Pharma Inc. Common Stock (HELP) in Q2 2024, closing a stake of 267 shares — an estimated $4.2K sold.

Fountainhead AM first reported a position in HELP in Q4 2023 and held it in 2 quarters. The position peaked at $4.2K in Q1 2024. 98 funds tracked by Wall St. Rank hold HELP as of Q2 2024.

  • Fountainhead AM reported no remaining Helus Pharma Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Fountainhead AM sold 267 Helus Pharma Inc. Common Stock shares in Q2 2024, an estimated $4.2K.
  • Fountainhead AM first reported a position in Helus Pharma Inc. Common Stock in Q4 2023 and held it in 2 quarters.
  • Fountainhead AM's Helus Pharma Inc. Common Stock position peaked at $4.2K in Q1 2024.
  • 98 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q2 2024.

Based on Fountainhead AM's 13F filing for Q2 2024, filed 26 Jul 2024.